by Jon Chesto for the Boston Globe

“After four long months, Jeff Leerink can breathe a little easier now: He’s back to calling the shots at the investment bank he grew from nothing into one of biotech’s biggest players, before teaming up with the ill-fated Silicon Valley Bank in 2019.

And Leerink is not the only one feeling some relief. Losing the investment bank he built would have been a big blow to Greater Boston’s life sciences industry, and the broader regional economy as a whole…”

Continue reading at the original source, linked here.